3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Glioblastoma
1
Interventions
Magnetic Resonance Spectroscopy
17
Blood Specimen Collection
8
Bevacizumab
8
Temozolomide
7
Radiotherapy
5
Palliative Care
4
Surgical Procedures, Operative
3
Restraint, Physical
3
Radiation
3
Biopsy
3
Yoga
2
Standard of Care
2
Specimen Handling
2
Radiotherapy, Intensity-Modulated
2
Radiosurgery
2
Psychosocial Intervention
2
Perfusion Magnetic Resonance Imaging
2
Mind-Body Therapies
2
Magnetic Resonance Imaging
2
Lomustine
2
Gadolinium DTPA
2
Elasticity Imaging Techniques
2
Early Intervention, Educational
2
Drug Therapy
2
Diet Therapy
2
Dexamethasone
2
Chemotherapy, Adjuvant
2
Aminolevulinic Acid
2
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
2
tislelizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Glioblastoma
×
Cell Count
×
Clear all
NCT07144735
2025-08-27
ABOUT
Peking University Third Hospital
Phase NA
Recruiting
18 enrolled